The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
Abstract
In Alzheimer's disease, age-related cellular changes such as compromised energy production and increased radical formation are worsened by the presence of AGEs as additional, AD specific stress factors. Intracellular AGEs (most likely derived from methylglyoxal) crosslink cytoskeletal proteins and render them insoluble. These aggregates inhibit cellular functions including transport processes and contribute to neuronal dysfunction and death. Extracellular AGEs, which accumulate in ageing tissue (but most prominently on long-lived protein deposits like the senile plaques) exert chronic oxidative stress on neurons. In addition, they activate glial cells to produce free radicals (superoxide and NO) and neurotoxic cytokines such as TNF-alpha. Drugs, which inhibit the formation of AGEs by specific chemical mechanisms (AGE-inhibitors), including aminoguanidine, carnosine, tenilsetam, OPB-9195 and pyridoxamine, attenuate the development of (AGE-mediated) diabetic complications. Assuming that 'carbonyl stress' contributes significantly to the progression of Alzheimer's disease, AGE-inhibitors might also become interesting novel therapeutic drugs for treatment of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of RAGE by its ligands upregulates inflammatory signalling pathways including NF-κB, phosphoinositide 3-kinase, JAK-STAT and MAPK, leading to induction of pro-inflammatory cytokines such as TNF.
“Activation of RAGe by its ligands results in the upregulation of several inflammatory signalling pathways, including, but not limited to, NF-κb, phospho inositide 3-kinase, Janus kinase (JAK)–signal transducer and activator of transcription (STAT) and MAPK signalling pathways, which lead to induction of pro-inflammatory cytokines such as TNF19,91,95,96.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [96]
Citations
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Staging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · cited 5×
“An acute decrease in cellular GSH, as occurs in oxidative stress, leads to decreased in situ activity of glyoxalase I, accumulation of -oxoaldehydes and cytotoxicity ( Abordo et al. 1999 ).”
BackgroundInfluentialLander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Bush, A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00073-3 · Cited by 731
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 715
Wells‐Knecht, K. J., Zyzak, D. V., Litchfield, J., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00011a027 · Cited by 594
Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P. J., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea, A., Harris, P. L. R., Webster, K. R., Wahl, A. F., & Smith, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 422
Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases
Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., WAKAYAMA, I., Yanagihara, R. T., Garruto, R. M., et al. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65659-3 · Cited by 411
Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M. A., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Müller, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1481 · Cited by 371
Analysis of microtubule-associated protein tau glycation in paired helical filaments.
Ledesma, M. D., Bonay, P., Colaço, C., & Avila, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31849-5 · Cited by 333 · cited 1×
“It has been shown that MAP-τ , the major component of NFTs, is AGE-modified in affected neurons, whereas soluble MAP-τ from either AD or non-demented human brains is not AGE-modified at all (Ledesma et al. 1994).”
BackgroundAdvanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C., Vlassara, H., Peten, E. P., He, C., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 293
Advanced glycation end products: A nephrologist's perspective
Raj, D. S., Choudhury, D., Welbourne, T., & Levi, M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70189-2 · Cited by 288
Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation Reactions
Khalifah, R. G., Baynes, J., & Hudson, B. G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0371 · Cited by 268
Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease
Lars Rödel, T. A., Gärtner, U., & Holzer, M. (1996) · NeuroReport · doi:10.1097/00001756-199611250-00050 · Cited by 250
Onorato, J. M., Jenkins, A. J., Thorpe, S. R., & Baynes, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003263200 · Cited by 250
Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y., & Quirion, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91327-o · Cited by 244
Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease
Mattson, M. P., Barger, S. W., Furukawa, K., Bruce‐Keller, A. J., Wyss‐Coray, T., Mark, R. J., & Mucke, L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00014-8 · Cited by 243
Accumulation of α-oxoaldehydes during oxidative stress: a role in cytotoxicity
Abordo‐Adesida, E., Minhas, H. S., & Thornalley, P. J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00132-x · Cited by 239
Nakamura, S., Makita, Z., Ishikawa, S., YASUMURA, K., Fujii, W., Yanagisawa, K., Kawata, T., & Koike, T. (1997) · Diabetes · doi:10.2337/diab.46.5.895 · Cited by 234
The role of cell cycle‐mediated events in Alzheimer's disease
Raina, A. K., Monteiro, M. J., McShea, A., & Smith, M. A. (1999) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1999.00106.x · Cited by 224
Hipkiss, A. R., Michaelis, J., & Syrris, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00849-5 · Cited by 222
Redox metals and neu rodegenerative disease
Sayre, L. M., Perry, G. L., & Smith, M. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80035-0 · Cited by 217
Tsuchida, K., Makita, Z., Yamagishi, S., Atsumi, T., Miyoshi, H., OBARA, S., Ishida, M., Ishikawa, S., YASUMURA, K., & Koike, T. (1999) · Diabetologia · doi:10.1007/s001250051198 · Cited by 214
Mehlhorn, G., Hollborn, M., & Schliebs, R. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00012-5 · Cited by 199
Booth, A. A., Khalifah, R. G., & Hudson, B. G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0366 · Cited by 195
Neumann, A., Schinzel, R., Palm, D., Riederer, P. F., & Münch, G. W. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00731-0 · Cited by 195
Self-citationMiyata, T., Ueda, Y., Yamada, Y., Izuhara, Y., Wada, T., Jadoul, M. Y., Saitō, A., Kurokawa, K., & de Strihou, C. V. Y. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9122349 · Cited by 188
Sheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01063.x · Cited by 181
A Redox-triggered Ras-Effector Interaction
Deora, A. A., Win, T., Vanhaesebroeck, B., & Lander, H. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29923 · Cited by 178
Carnosine, a protective, anti-ageing peptide?
Hipkiss, A. R. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00060-0 · Cited by 174
Münch, G. W., Mayer, S., Michaelis, J., Hipkiss, A. R., Riederer, P. F., Müller, R., Neumann, A., Schinzel, R., & Cunningham, A. M. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(96)00062-2 · Cited by 174
Self-citationSugimoto, H., Shikata, K., Wada, J., Horiuchi, S., & Makino, H. (1999) · Diabetologia · doi:10.1007/s001250051241 · Cited by 151
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress
Loske, C., Neumann, A., Cunningham, A. M., Nichol, K. A., Schinzel, R., Riederer, P. F., & Münch, G. W. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050108 · Cited by 144
Self-citationPreston, J. E., Hipkiss, A. R., Himsworth, D. T. J., Romero, I. A., & Abbott, J. N. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00058-5 · Cited by 137
Horie, K., Miyata, T., Yasuda, T., Takeda, A., Yasuda, Y., Maeda, K., Sobue, G., & Kurokawa, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6944 · Cited by 137
Pugliese, G., Pricci, F., Romeo, G. R., Pugliese, F. R., Mené, P., Giannini, S., Cresci, B., Galli, G., Rotella, C. M., Vlassara, H., et al. (1997) · Diabetes · doi:10.2337/diab.46.11.1881 · Cited by 135
Qian, M., Liu, M., & Eaton, J. W. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9326 · Cited by 126
Hirata, C., Nakano, K., Nakamura, N., Kitagawa, Y., Shigeta, H., Hasegawa, G., Ogata, M., Ikeda, T., Sawa, H., Nakamura, K., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7036 · Cited by 118
Zimmerman, G. A., Meistrell, M. E., Bloom, O., Cockroft, K. M., Bianchi, M., Risucci, D. A., Broome, J., Farmer, P., Cerami, A., & Vlassara, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3744 · Cited by 111
Carnosine reacts with a glycated protein
Brownson, C., & Hipkiss, A. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00270-7 · Cited by 110
τ Protein from Alzheimer's Disease Patients Is Glycated at Its Tubulin‐Binding Domain
Ledesma, M. D., Bonay, P., & Avila, J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041658.x · Cited by 109
Transition metal‐mediated glycoxidation accelerates cross‐linking of β‐amyloid peptide
Loske, C., Gerdemann, A., Schepl, W., Wycislo, M., Schinzel, R., Palm, D., Riederer, P. F., & Münch, G. W. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01452.x · Cited by 108
Self-citationAdvanced Glycation Endproducts Stimulate Interleukin-6 Production by Human Bone-Derived Cells
Takagi, M., Kasayama, S., Yamamoto, T., Motomura, T., Hashimoto, K., Yamamoto, H., Sato, B., Okada, S., & Kishimoto, T. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.3.439 · Cited by 104
Lo, T. W. C., Selwood, T., & Thornalley, P. J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90584-3 · Cited by 102
Kunt, T., Forst, T. M., Wilhelm, A., Tritschler, H., PFUETZNER, A., Harzer, O., Engelbach, M., ZSCHAEBITZ, A., Stofft, E., & Beyer, J. (1999) · Clinical Science · doi:10.1042/cs0960075 · Cited by 87
Castellani, R., Smith, M. A., Nunomura, A., Harris, P., & Perry, G. (1999) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(99)00016-7 · Cited by 87
RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease.
Yan, S. S., Stern, D. M., Kane, M. D., Kuo, Y., Lampert, H. C., & Roher, A. E. (1998) · PubMed · Cited by 83
Induction of p21ras in Alzheimer pathology
Gärtner, U., Holzer, M., Heumann, R., & Arendt, T. (1995) · Neuroreport · doi:10.1097/00001756-199507100-00020 · Cited by 81
Miyata, T., Ishikawa, S., Asahi, K., Inagi, R., Suzuki, D., Horie, K., Tatsumi, K., & Kurokawa, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00122-2 · Cited by 80
Hoyaux, D., Decaestecker, C., Heizmann, C. W., Vogl, T. J., Schäfer, B. W., Salmon, I. J., Robert Kiss, A., & Pochet, R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02393-3 · Cited by 79
Glycation and Microglial Reaction in Lesions of Alzheimer's Disease
Dickson, D. W., Sinicropi, S., Yen, S.-H. C., Ko, L., Mattiace, L. A., Bucala, R., & Vlassara, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00116-9 · Cited by 76
Advanced glycation endproducts stimulate the MAP‐kinase pathway in tubulus cell line LLC‐PK1
Simm, A., Münch, G. W., Seif, F., Schenk, O., Heidland, A., Richter, H., Vamvakas, S., & Schinzel, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00644-3 · Cited by 75
Self-citationHuang, J., Guh, J., Hung, W., Yang, M., Lai, Y., Chen, H., & Chuang, L. (1999) · Biochemical Journal · doi:10.1042/bj3420231 · Cited by 73
Takeda, A., Yasuda, T., Miyata, T., Goto, Y., Wakai, M., Watanabe, M., Yasuda, Y., Horie, K., Inagaki, T., Doyu, M., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050839 · Cited by 71
Münch, G. W., Taneli, Y., Schraven, E., Schindler, U., Schinzel, R., Palm, D., & Riederer, P. F. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260940 · Cited by 69
Self-citationAn immunochemical study on tau glycation in paired helical filaments
Ko, L., Ko, E. C., Nacharaju, P., Liu, W.-K., Chang, E. C., Kenessey, Á., & Yen, S.-H. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01415-8 · Cited by 68
The Role of the Axonal Cytoskeleton in Diabetic Neuropathy
McLean, W. G. (1997) · Neurochemical Research · doi:10.1023/a:1022466624223 · Cited by 66
Age-dependent accumulation of advanced glycosylation end products in human neurons
Li, J., Surini, M., Catsicas, S., Kawashima, E. H., & Bouras, C. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80009-g · Cited by 66
Carbonyl compounds cross-link cellular proteins and activate protein-tyrosine kinase p60c-Src
Akhand, A. A., Kato, M., Suzuki, H., Liu, W., Du, J., Hamaguchi, M., Miyata, T., Kurokawa, K., & Nakashima, I. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990101)72:1 · Cited by 63
Li, Y. M., & Dickson, D. W. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00266-8 · Cited by 62
Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain
Takeda, A., Yasuda, T., Miyata, T., Mizuno, K., Li, M., YONEYAMA, S., Horie, K., Maeda, K., & Sobue, G. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13275-4 · Cited by 62
On the structure of microtubules, tau, and paired helical filaments
Mandelkow, E., Song, Y., Schweers, O., Marx, A., & Mandelkow, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00026-b · Cited by 60
Thornalley, P. J., & Minhas, H. S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00284-6 · Cited by 59
Inhibitory Effects of Tenilsetam on the Maillard Reaction
Shoda, H., Miyata, S., Liu, B.-F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M., & Kasuga, M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5151 · Cited by 59
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease
Münch, G. W., Cunningham, A. M., Riederer, P. F., & Braak, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00328-x · Cited by 57
Self-citationAbordo‐Adesida, E., & Thornalley, P. J. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00080-1 · Cited by 56
Kimura, T., Takamatsu, J., Miyata, T., Miyakawa, T., & Horiuchi, S. (1998) · Pathology International · doi:10.1111/j.1440-1827.1998.tb03953.x · Cited by 51
Abordo‐Adesida, E., Westwood, M. E., & Thornalley, P. J. (1996) · Immunology Letters · doi:10.1016/0165-2478(96)02601-6 · Cited by 47
Yamamoto, Y., Yamagishi, S., Hsu, C., & Yamamoto, H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0807 · Cited by 46
The role of the Maillard reaction in other pathologies: Alzheimer's disease
Colaco, C. A. L. S., Ledesma, M. D., Harrington, C. R., & Ávila, J. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.7 · Cited by 37
Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts
Lal, S., Randall, W. C., Taylor, A. H., Kappler, F. E., Walker, M. A., Brown, T. R., & Szwergold, B. S. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90240-7 · Cited by 34
Carnosine prevents glyceraldehyde 3-phosphate-mediated inhibition of aspartate aminotransferase
Swearengin, T. A., Fitzgerald, C., & Seidler, N. W. (1999) · Archives of Toxicology · doi:10.1007/s002040050623 · Cited by 28
Tau glycation is involved in aggregation of the protein but not in the formation of filaments.
Ledesma, M. D., Pérez, M., Colaco, C. A. L. S., & Ávila, J. (1998) · PubMed · Cited by 25
Neuropathology of diabetic neuropathy and its correlations with neurophysiology.
Sima, A. A. F., & Cherian, P. (1997) · PubMed · Cited by 19
Ihl, R., Perisic, I., Maurer, K., & Dierks, T. (1989) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02312253 · Cited by 17
Kimura, T., & Horiuchi, S. (1995) · Neuroreport · doi:10.1097/00001756-199508000-00002 · Cited by 6
MODEL STUDIES OF THE MAILLARD REACTION OF ARG-LYS WITH D-GLUCOSE
Al‐Abed, Y., Callaway, D. J. E., Kapurniotu, A., Holak, T. A., Voelter, W., & Bucala, R. (1999) · Polish Journal of Chemistry · Cited by 2
Flagged first, then by citations
1 of the 83 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Czech C, Monning U, Tienari PJ, Hartmann T, Masters C, Beyreuther K and Forstl H (1993) Apolipoprotein-e-sigma-4 allele and alzheimers disease. Lancet 342: 1309-1310
- Khalifah RG, Baynes JW and Hudson BG (1999) Amadorins: Novel post-Amadori inhibitors of advanced glycation reactions. Biochem Biophys Res Commun 257: 251-258 · DOI
Cited by
Sorted by citations
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity
Calabrese, V., Cornelius, C., Dinkova‐Kostova, A. T., Iavicoli, I., Paola, R. D., Koverech, A., Cuzzocrea, S., Rizzarelli, E., & Calabrese, E. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.002 · Cited by 424
Theories of biological aging: Genes, proteins, and free radicals
Rattan, S. I. S. (2006) · Free Radical Research · doi:10.1080/10715760600911303 · Cited by 374
Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy
Praticò, D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.010 · Cited by 317
Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, T. E., Stella, A. M. G., Schapira, T., Dinkova‐Kostova, A. T., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9775-9 · Cited by 273
Current drug targets for Alzheimer's disease treatment
Lahiri, D. K., Farlow, M. R., Greig, N. H., & Sambamurti, K. (2002) · Drug Development Research · doi:10.1002/ddr.10081 · Cited by 220
Valente, T., Gella, A., Fernàndez‐Busquets, X., Unzeta, M., & Durany, N. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.008 · Cited by 209
Yan, W., Chen, L., Chen, J., Ge, L., & He, R. Q. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-10 · Cited by 208
Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity
Calabrese, V., Cornelius, C., Cuzzocrea, S., Iavicoli, I., Rizzarelli, E., & Calabrese, E. J. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.007 · Cited by 197
Voziyan, P., & Hudson, B. G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5082-7 · Cited by 190
Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases
GRILLO, M. A., & Colombatto, S. (2007) · Amino Acids · doi:10.1007/s00726-007-0606-0 · Cited by 184
Salahuddin, P., Rabbani, G., & Khan, R. H. (2014) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-014-0205-5 · Cited by 175
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation
Guglielmotto, M., Aragno, M., Tamagno, E., Vercellinatto, I., Visentin, S., Medana, C., Catalano, M. G., Smith, M. A., Perry, G. L., Danni, O., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.026 · Cited by 163
Aldini, G., Vistoli, G., Štefek, M., Chondrogianni, N., Grune, T., Sereikaitė, J., Sadowska‐Bartosz, I., & Bartosz, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.792926 · Cited by 154
Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases
Baig, M. H., Ahmad, K., Saeed, M., Alharbi, A. M., Barreto, G. E., Ashraf, G. M., & Choi, I. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.025 · Cited by 154
Ahmed, N., & Thornalley, P. J. (2002) · Biochemical Journal · doi:10.1042/bj3640015 · Cited by 152
Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases
Calabrese, V. (2009) · Frontiers in bioscience · doi:10.2741/3250 · Cited by 145
Differential effects of glycation on protein aggregation and amyloid formation
Iannuzzi, C., Irace, G., & Sirangelo, I. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00009 · Cited by 143
Increased molecular damage and heterogeneity as the basis of aging
Rattan, S. I. S. (2008) · Biological Chemistry · doi:10.1515/bc.2008.030 · Cited by 142
Burkholderia cepacia lipase: A versatile catalyst in synthesis reactions
Sánchez, D. A., Tonetto, G. M., & Ferreira, M. L. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26458 · Cited by 142
de Arriba, S. G., Stuchbury, G., Yarin, J., Burnell, J. N., Loske, C., & Münch, G. W. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.007 · Cited by 137
Self-citationOxidative Stress, Antioxidants and Neurodegenerative Diseases
Casetta, I., Govoni, V., & Granieri, E. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054065729 · Cited by 135
Anti-crosslinking properties of carnosine: Significance of histidine
Hobart, L. J., Seibel, I., Yeargans, G. S., & Seidler, N. W. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.002 · Cited by 135
Advanced glycation endproducts and their pathogenic roles in neurological disorders
Münch, G. W., Westcott, B., Menini, T., & Gugliucci, A. (2010) · Amino Acids · doi:10.1007/s00726-010-0777-y · Cited by 133
Self-citationCarnosine: A Versatile Antioxidant and Antiglycating Agent
Reddy, V. P., Garrett, M. R., Perry, G. L., & Smith, M. A. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.18.pe12 · Cited by 132
Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD
Wu, L., Ma, L., Nicholson, L. F. B., & Black, P. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.11.001 · Cited by 126
Evaluation of rage isoforms, ligands, and signaling in the brain
Ding, Q., & Keller, J. N. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.08.006 · Cited by 120
Millington, C., Sonego, S., Karunaweera, N., Rangel, A., Aldrich-Wright, J. R., Campbell, I. L., Gyengési, E., & Münch, G. W. (2014) · BioMed Research International · doi:10.1155/2014/309129 · Cited by 118
Self-citationPyridoxamine: The Many Virtues of a Maillard Reaction Inhibitor
Voziyan, P., & Hudson, B. G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.093 · Cited by 117
Krautwald, M., & Münch, G. W. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.001 · Cited by 116
Self-citationPolyphenols in Alzheimer’s Disease and in the Gut–Brain Axis
Reddy, V. P., Aryal, P., Robinson, S., Rafiu, R., Obrenovich, M. E., & Perry, G. L. (2020) · Microorganisms · doi:10.3390/microorganisms8020199 · Cited by 115
d-ribose in glycation and protein aggregation
Yan, W., Han, C. S., Zhou, J., Liu, Y. M., Chen, L., & He, R. Q. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.01.005 · Cited by 114
Carnosinases, Their Substrates and Diseases
Bellia, F., Vecchio, G., & Rizzarelli, E. (2014) · Molecules · doi:10.3390/molecules19022299 · Cited by 113
Dmitriev, L. F., & Титов, В. Н. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.09.004 · Cited by 105
Involvement of maillard reactions in Alzheimer disease
Reddy, V. P., Obrenovich, M. E., Atwood, C., Perry, G. L., & Smith, M. A. (2002) · Neurotoxicity Research · doi:10.1080/1029840290007321 · Cited by 101
Scott, S., Loera, S., Tessler, C., Chu, P., Weiss, L. M., Hardy, J. W., Rahbar, S., & Figarola, J. L. (2003) · Diabetologia · doi:10.1007/s00125-003-1162-0 · Cited by 96
Verbeke, P. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00752-3 · Cited by 90
Webster, J. A., Urban, C., Berbaum, K., Loske, C., Alpár, A., Gärtner, U., de Arriba, S. G., Arendt, T., & Münch, G. W. (2005) · Neurotoxicity Research · doi:10.1007/bf03033780 · Cited by 85
Self-citationSarmah, S., & Roy, A. S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.041 · Cited by 74
Wood, P. L., Khan, M. A., Kulow, S. R., Mahmood, S. A., & Moskal, J. R. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.038 · Cited by 69
Carnosinase Levels in Aging Brain: Redox State Induction and Cellular Stress Response
Bellia, F., Calabrese, V., Guarino, F., Cavallaro, M., Cornelius, C., Pinto, V. D., & Rizzarelli, E. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2738 · Cited by 68
Chandler, D., Woldu, A. S., Rahmadi, A., Shanmugam, K., Steiner, N., Wright, E. P., Benavente-García, O., Schulz, O., Castillo, J., & Münch, G. W. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900504 · Cited by 65
Self-citationDegradation of glycated bovine serum albumin in microglial cells
Stolzing, A., Widmer, R., Jung, T., Voß, P., & Grune, T. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.061 · Cited by 61
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain
Riederer, P. F., & Hoyer, S. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0591-6 · Cited by 56
Self-citationYan, W., Han, C., Wang, Y., Wu, B., Su, T., Liu, Y., & He, R. (2015) · Aging Cell · doi:10.1111/acel.12355 · Cited by 53
Bellia, F., Amorini, A. M., Mendola, D. L., Vecchio, G., Tavazzi, B., Giardina, B., Pietro, V. D., Lazzarino, G., & Rizzarelli, E. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.03.038 · Cited by 50
On the mechanisms of ageing suppression by dietary restriction—is persistent glycolysis the problem?
Hipkiss, A. R. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.006 · Cited by 50
Protection of proteins from oxidative stress: a new illusion or a novel strategy?
BOLDYREV, A. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1356.013 · Cited by 49
Azam, H. M. H., Rößling, R., Geithe, C., Khan, M. M., Dinter, F., Hanack, K., Prüß, H., Husse, B., Roggenbuck, D., Schierack, P., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1386735 · Cited by 48
Edaravone Protects against Methylglyoxal-Induced Barrier Damage in Human Brain Endothelial Cells
Tóth, A. E., Walter, F. R., Bocsik, A., Sántha, P., Veszelka, S., Nagy, L. I., Puskás, L. G., Couraud, P., Takata, F., Dohgu, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100152 · Cited by 46
Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126
Kawahara, M., Koyama, H., Nagata, T., & Sadakane, Y. (2011) · Metallomics · doi:10.1039/c1mt00015b · Cited by 44
Nenna, A., Spadaccio, C., Lusini, M., Ulianich, L., Chello, M., & Nappi, F. (2016) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/1574890110666151104120039 · Cited by 43
Protein Carbonylation in Neurodegenerative and Demyelinating CNS Diseases
Bizzozero, O. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_23 · Cited by 43
de Hemptinne, V., Rondas, D., Toepoel, M., & Vancompernolle, K. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0031-7 · Cited by 42
Kim, Y. S., Kim, N. H., Lee, S., Lee, Y. M., Jang, D. S., & Kim, J. S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.054 · Cited by 42
Fernàndez‐Busquets, X., Ponce, J., Bravo, R., Arimon, M., Martiáñez, T., Gella, A., Cladera, J., & Durany, N. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383787 · Cited by 38
Chowdhury, A. A., Gawali, N. B., Bulani, V. D., Kothavade, P. S., Mestry, S. N., Deshpande, P. S., & Juvekar, A. R. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.09.006 · Cited by 37
Does Chronic Glycolysis Accelerate Aging? Could This Explain How Dietary Restriction Works?
Hipkiss, A. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.051 · Cited by 36
Kaur, A., Singh, B., Vyas, B., & Silakari, O. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.022 · Cited by 36
Haug, A., Rødbotten, R., Mydland, L. T., & Christophersen, O. A. (2008) · Acta Agriculturae Scandinavica Section A – Animal Science · doi:10.1080/09064700802213545 · Cited by 36
Compounds Blocking Methylglyoxal-induced Protein Modification and Brain Endothelial Injury
Tóth, A. E., Tóth, A., Walter, F. R., Kiss, L., Veszelka, S., Ózsvári, B., Puskás, L. G., Heimesaat, M. M., Dohgu, S., Kataoka, Y., et al. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.10.009 · Cited by 34
Glycation Accelerates Fibrillization of the Amyloidogenic W7FW14F Apomyoglobin
Iannuzzi, C., Maritato, R., Irace, G., & Sirangelo, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080768 · Cited by 34
RetractedAmyloid-β Metabolite Sensing: Biochemical Linking of Glycation Modification and Misfolding
Fawver, J. N., Schall, H. E., Chapa, R. P., Zhu, X., & Murray, I. V. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112114 · Cited by 31
Brain type carnosinase in dementia: a pilot study
Balion, C. M., Benson, C. M., Raina, P. S., Παπαϊωάννου, Α., Patterson, C., & Ismaila, A. (2007) · BMC Neurology · doi:10.1186/1471-2377-7-38 · Cited by 30
Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer’s disease
Münch, G. W., Gasic‐Milenkovic, J., & Arendt, T. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0643-3_4 · Cited by 30
Self-citationSarmah, S., Goswami, A., Belwal, V. K., & Roy, A. S. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111358 · Cited by 29
Glycation of extracellular matrix proteins impairs migration of immune cells
Haucke, E., Santos, A. N., Simm, A., Silber, R., & Hofmann, B. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12144 · Cited by 29
Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention
Brás, I. C., König, A., & Outeiro, T. F. (2019) · Journal of Huntington s Disease · doi:10.3233/jhd-190366 · Cited by 29
Can cognitive deterioration associated with Down syndrome be reduced?
van Thiel, R. J., & Fowkes, S. W. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.020 · Cited by 29
d-ribose and pathogenesis of Alzheimer’s disease
Javed, M., Ahmad, M. I., Javed, H., & Naseem, S. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05243-7 · Cited by 27
Cheng, G., Wang, L., Wen-sheng, Q. U., Long, L., Cui, H. Z., Liu, H., Cao, Y.-L., & Li, S. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00240.x · Cited by 27
Valente, T., Gella, A., Solé, M., Durany, N., & Unzeta, M. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23092 · Cited by 26
Carnosine promotes the heat denaturation of glycated protein
Yeargans, G. S., & Seidler, N. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02796-1 · Cited by 26
Dhananjayan, K., Gunawardena, D., Hearn, N., Sonntag, T., Moran, C., Gyengesi, E., Srikanth, V., & Münch, G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161152 · Cited by 24
Self-citationThe concept of protein folding/unfolding and its impacts on human health
Alaei, L., Ashengroph, M., & Moosavi‐Movahedi, A. A. (2021) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.01.007 · Cited by 23
Sasaki, N. A., Garcia-Alvarez, M. C., Wang, Q., Ermolenko, L. P., Franck, G., Nhiri, N., Martin, M., Audic, N., & Potìer, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.018 · Cited by 23
Mechanisms of protein misfolding: Novel therapeutic approaches to protein-misfolding diseases
Salahuddin, P., Siddiqi, M. K., Khan, S., Abdelhameed, A. S., & Khan, R. H. (2016) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2016.06.046 · Cited by 23
de Hemptinne, V., Rondas, D., Vandekerckhove, J. S., & Vancompernolle, K. (2007) · Biochemical Journal · doi:10.1042/bj20070379 · Cited by 22
Role of the Glyoxalase System in Alzheimer’s Disease
Jiang, L., Wang, J., Wang, Z., Huang, W., Yang, Y., Cai, Z., & Li, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180413 · Cited by 20
Auburger, G. W. J., & Kurz, A. (2011) · Aging · doi:10.18632/aging.100258 · Cited by 19
Flavor Addition in Dairy Products
Kumar, N., Raghavendra, M., Tokas, J., & Singal, H. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809762-5.00010-3 · Cited by 17
Enzymatic synthesis of carnosine derivatives catalysed by Burkholderia cepacia lipase
D’Arrigo, P., Kanerva, L. T., Li, X., Saraceno, C., Servi, S. D., & Tessaro, D. (2009) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2009.05.040 · Cited by 15
Proteins: Structure, properties, and importance
Prasad, B., Shiv, A. K., Bharati, A. C., & Mallick, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91684-4.00003-7 · Cited by 14
Dabhade, P., & Kotwal, S. D. (2013) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.753777 · Cited by 14
Efficacy of thermal stimulation on wrinkle removal via the enhancement of collagen synthesis
Yamämoto, Y., Obayashi, K., Okano, Y., Satoh, Y., Masaki, H., & Funasaka, Y. (2006) · Journal of Dermatological Science Supplement · doi:10.1016/j.descs.2006.08.006 · Cited by 14
Singh, R. J., Hussain, J., Kaur, A., Jamdare, B. G., Pathak, D., Garg, K., Kaur, R., Shankar, S., & Sunkaria, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102002 · Cited by 13
Khalifa, I., Sobhy, R., Nawaz, A., Wei, X., Li, Z., & Zou, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.243 · Cited by 12
Carnosine and Anserine in Chicken: Distribution, Age-dependency and their Anti-glycation Activity
Kim, S., Kim, Y., Baek, I.-K., & Auh, J. (2012) · Korean Journal for Food Science of Animal Resources · doi:10.5851/kosfa.2012.32.1.45 · Cited by 11
Investigation and isolation of peptide based antiglycating agents from various sources
Kani, H. K., Kocazorbaz, E. K., & Zihnioğlu, F. (2019) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2018-0294 · Cited by 10
Unchanged serum levels of advanced glycation endproducts in patients with liver disease
Butscheid, M., Schäfer, C., Brenner, S. S., Alscher, M. D., Mürdter, T. E., Niwa, T., Frischmann, M., Pischetsrieder, M., & Klotz, U. E. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0171-9 · Cited by 10
Weinstein, J. D., Gonzalez, E. R., Egleton, R. D., & Hunt, D. A. (2013) · The Consultant Pharmacist · doi:10.4140/tcp.n.2013.443 · Cited by 9
Glycation of human serum albumin affects its binding affinity towards (−)-epigallocatechin gallate
Roy, A. S., Ghosh, P., & Dasgupta, S. (2016) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-016-0619-y · Cited by 9
Optimizing Carnosine Containing Extract Preparation from Chicken Breast for Anti-glycating agents
Kim, S.-K., Kwon, D., Kwon, D., Paik, I. K., & Auh, J. (2014) · Korean Journal for Food Science of Animal Resources · doi:10.5851/kosfa.2014.34.1.127 · Cited by 9
Dmitriev, L. F., & Дугин, С. Ф. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701384783 · Cited by 8
Phytochemical and Bioactivity Analysis of Several Methanolic Extracts of Nine Bryophytes Species
Kocazorbaz, E. K., Tok, K., Moulahoum, H., & Ün, R. N. (2021) · Sakarya University Journal of Science · doi:10.16984/saufenbilder.868944 · Cited by 8
Role of Glycation in Amyloid: Effect on the Aggregation Process and Cytotoxicity
Iannuzzi, C., Irace, G., & Sirangelo, I. (2016) · InTech eBooks · doi:10.5772/62995 · Cited by 8
Safety issues of methylglyoxal and potential scavengers
Li, S., Liu, S., & Ho, C. (2018) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2017174 · Cited by 8
Webster, J. A., Wilke, M., Stahl, P., Kientsch-Engel, R., & Münch, G. W. (2005) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-005-0263-4 · Cited by 7
Self-citationGlycation of Liver Cystatin: Implication on its Structure and Function
Mustafa, M. F., & Bano, B. (2016) · Journal of Fluorescence · doi:10.1007/s10895-016-1866-4 · Cited by 5
Impact of glucose levels on advanced glycation end products in hemodialysis
Godfrey, A. R. (2007) · Hemodialysis International · doi:10.1111/j.1542-4758.2007.00180.x · Cited by 5
Metadata
- Authors
- Dukic-Stefanovic, S., Schinzel, R., Riederer, P., & Münch*, G.
- Affiliations
- University of Würzburg (DE)
- Venue
- Biogerontology
- Published
- 2001-03
- Volume
- 2
- Issue
- 1
- Pages
- 19-34
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- OpenAlex
- W17453112
- Cited by
- 113
- References
- 83
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 1 · 2014: 9 · 2013: 4 · 2012: 4
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Biogerontology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Keywords
- advanced glycation end products, AGE inhibitors, Alzheimer's disease, neuroprotection, anti-dementia drugs, methylglyoxal, carbonyl stress, oxidative stress, amyloid plaques, aminoguanidine, carnosine, pyridoxamine, glial activation, neuronal dysfunction, brain aging
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Dementia, Humans, Signal Transduction, Glycation End Products, Advanced, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review